RKIP Downregulation Induces the HBx-Mediated Raf-1 Mitochondrial Translocation |
Kim, Sun-Young
(Medical Proteomics Research Center, KRIBB)
Park, Sung-Goo (Medical Proteomics Research Center, KRIBB) Jung, Hye-Yun (Medical Proteomics Research Center, KRIBB) Chi, Seung-Wook (Medical Proteomics Research Center, KRIBB) Yu, Dae-Yeul (Ageing Research Center, KRIBB) Lee, Sang-Chul (Medical Proteomics Research Center, KRIBB) Bae, Kwang-Hee (Medical Proteomics Research Center, KRIBB) |
1 | Alexia, C., G. Fallot, M. Lasfer, G. Schweizer-Groyer, and A. Groyer. 2004. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signaling in hepatocarcinogenesis and in the resistance of the hepatocarcinoma cells against drug-induced apoptosis. Biochem. Pharmacol. 68: 1003-1015. DOI ScienceOn |
2 | Chen, J. and A. Siddiqui. 2007. Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress. J. Virol. 81: 6757-6760. DOI ScienceOn |
3 | Corbit, K. C., N. Trakul, E. M. Eves, B. Diaz, M. Marshall, and M. R. Rosner. 2003. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J. Biol. Chem. 278: 13061-13068. DOI |
4 | Granovsky, A. E. and M. R. Rosner. 2008. Raf kinase inhibitory protein: A signal transduction modulator and metastasis suppressor. Cell Res. 18: 452-457. DOI ScienceOn |
5 | Klysik, J., S. J. Theroux, J. M. Sedivy, J. S. Moffit, and K. Boekelheide. 2008. Signaling crossroads: The function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal. 20: 1-9. DOI ScienceOn |
6 | Lee, H. C., B. Tian, J. M. Sedivy, J. R. Wands, and M. Kim. 2006. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology. 131: 1208-1217. DOI ScienceOn |
7 | Lee, T. K., T. C. Lau, and I. O. Ng. 2002. Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines. Cancer Chemother. Pharmacol. 49: 78-86. DOI ScienceOn |
8 | Lee, Y. I., J. M. Hwang, J. H. Im, Y. I. Lee, N. S. Kim, D. G. Kim, et al. 2004. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J. Biol. Chem. 279: 15460-15471. DOI |
9 | Kim, S.-Y., P. Y. Lee, H.-J. Shin, D. H. Kim, S. Kang, H.-B. Moon, et al. 2009. Proteomic analysis of liver tissue from HBxtransgenic mice at early stages of hepatocarcinogenesis. Proteomics 9: 5056-5066. DOI ScienceOn |
10 | Neuveut, C., Y. Wei, and M. A. Buendia. 2010. Mechanisms of HBV-related hepatocarcinogenesis. J. Hepatol. 52: 594-604. DOI ScienceOn |
11 | Odabaei, G., D. Chatterjee, A. R. Jazirehi, L. Goodglick, K. Yeung, and B. Bonavida. 2004. Raf-1 kinase inhibitor protein: Structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv. Cancer Res. 91: 169-200. |
12 | Jeon, Y.-J., D.-H. Kim, H. Jung, S. J. Chung, S.-W. Chi, S. Cho, et al. 2010. Annexin A4 interacts with the NF-B p50 subunit and modulates NF-B transcriptional activity in a -dependent manner. Cell Mol. Life Sci. 67: 2271-2281. DOI ScienceOn |
13 | Schuierer, M. M., F. Bataille, T. S. Weiss, C. Hellerbrand, and A. K. Bosserhoff. 2006. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol. Rep. 16: 451-456. |
14 | Tang, H., N. Oishi, S. Kaneko, and S. Murakami. 2006. Molecular functions and biological roles of hepatitis B virus X protein. Cancer Sci. 97: 977-983. DOI ScienceOn |
15 | Xu, Y.-F., Y. Yi, S.-J. Qiu, Q. Gao, Y.-W. Li, C.-X. Dai, et al. 2010. PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection. J. Hepatol. 53: 872-879. DOI ScienceOn |